Alabama Internal Medicine, PC

Birmingham, Alabama 35235

0 studies enrolling now · 9 studies all time

What they study most

Atrial Fibrillation, Atrial Flutter, Diabetes Mellitus, Type 2, Hyperlipidemia, Hypertension, Male Hypogonadism, Urinary Bladder, Overactive

Studies at this site

• Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men — Completed
• CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes — Completed
• A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine. — Completed
• Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men — Completed
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events — Completed
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• Safety and Efficacy Trial of Testosterone Undecanoate — Completed
• DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension — Completed
• DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension — Stopped early